Veeva Systems Acquires Crossix Solutions for $430 Million

Parexel Acquires Vitrana

May 1, 2026

Healthcare Services

Parexel announced it has acquired Vitrana, an AI-enabled, end-to-end pharmacovigilance (PV) technology platform. The acquisition expands Parexel’s patient safety capabilities by integrating Vitrana’s AI automation into Parexel’s PV services to improve accuracy, cycle times, and compliance; financial terms were not disclosed.

Axtria Acquires Conexus Solutions

April 15, 2026

Data & Analytics

Axtria announced it is acquiring Conexus Solutions, a life sciences technology and managed services partner specializing in CRM transformation across the Veeva and Salesforce ecosystems. The deal expands Axtria into end-to-end life sciences CRM capabilities by combining Axtria’s agentic AI platform with Conexus’ CRM execution expertise for data-to-field-to-patient outcomes.

Options Technology Acquires Crossvale to Expand Private Cloud and Data Sovereign AI Modernization

February 15, 2026

Cloud & SaaS

Options Technology has agreed to acquire Crossvale to strengthen modernization capabilities for financial services clients, pairing Options’ secure private cloud platform with Crossvale’s application/platform modernization expertise. The combined offering is positioned to support “cloud repatriation,” reduce technical debt, and accelerate private cloud and AI adoption in secure, compliant models for regulated markets. Options later announced the acquisition was successfully completed.

Scipher Medicine Acquires CrossBridge to Add Real-time Patient Data and Analytics Platform

January 10, 2023

Data & Analytics

Scipher Medicine has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data management and analytics capabilities. The acquisition (closed; terms not disclosed) adds CrossBridge's SaaS value-based care platform to enable real-time mapping of patient molecular, clinical and claims data and to support Scipher's precision immunology offerings such as the PrismRA test.

Fresenius Kabi Acquires Ivenix

March 31, 2022

Medical Devices

Ivenix, Inc. has entered into a definitive agreement to be acquired by Fresenius Kabi for an upfront payment of $240 million plus additional milestone payments. The deal brings Ivenix's next-generation infusion pump technology and software together with Fresenius Kabi's IV fluids and infusion therapy portfolio to create a comprehensive infusion offering and accelerate U.S. commercial expansion.

TriNetX Acquires Advera Health Analytics

January 21, 2022

Data & Analytics

TriNetX has acquired Advera Health Analytics, the developer of the Evidex pharmacovigilance platform, to integrate Advera’s drug safety software and datasets into its real-world data network. The deal aims to give life sciences clients real-time safety signal detection, validation, and investigation capabilities by combining Evidex with TriNetX’s federated clinical datasets.